How many institutions held OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share in Q1 2026?

17 institutional investors reported OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share for Q1 2026. Use the holders table for investor-level position and value details.

Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM)

Q: What does CUSIP 690145206 represent in this 13F holders report?

CUSIP 690145206 is the security identifier for OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share used to aggregate holder disclosures.

CUSIP: 690145206

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, par value of $0.001 per share
Shares outstanding: 18,116,200
Total 13F shares: 792,343
Share change: +201,373
Total reported value: $3,042,597
Price per share: $3.84
Number of holders: 17
Value change: +$775,025
Number of buys: 11
Number of sells: 6

Quarterly Holders Quick Answers

What is CUSIP 690145206?
CUSIP 690145206 identifies OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 690145206:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13D/G 13F	Company	14%	2,596,861	$30,149,556	$0	31 Mar 2025	13D/G 13F
BlackRock, Inc.	13D/G 13F	Company	6.8%	1,213,547	$17,135,284	+$3,284,072	30 Sep 2025	13D/G 13F
Woodline Partners LP	13D/G 13F	Company	7.5%	1,325,784	$15,392,352	$0	31 Mar 2025	13D/G 13F
PERCEPTIVE ADVISORS LLC	13D/G 13F	Company	6.7%	1,208,334	$14,028,758	$0	31 Mar 2025	13D/G 13F
Alyeska Investment Group, L.P.	13D/G 13F	Company	9.6%	1,703,083	$9,896,956	$0	31 Mar 2025	13D/G 13F
BML Investment Partners, L.P.	13D/G	—	10%	1,902,201	$9,739,269	+$1,005,184	12 Feb 2026	13D/G
Braden M. Leonard	3/4/5	10%+ Owner	10%	1,902,201	$8,635,992	—	12 Feb 2026	3/4/5
BANK OF AMERICA CORP /DE/	13D/G 13F	Company	5.2%	950,558	$4,866,857	$0	31 Dec 2025	13D/G 13F
VANGUARD GROUP INC	13F	Company	5.4%	977,969	$3,628,265	—	31 Dec 2025	13F
Hackett Patrick T.	3/4/5	Director	1.2%	220,171	$3,368,614	—	02 Jun 2025	3/4/5
Ensign Peak Advisors, Inc	13F	Company	3.1%	560,169	$2,078,227	—	31 Dec 2025	13F
BML Capital Management, LLC	13F	Company	3%	543,180	$2,015,198	—	31 Dec 2025	13F
Renee Gaeta	3/4/5	Chief Financial Officer	0.73%	131,425	$2,010,802	—	10 Jun 2025	3/4/5
PFM Health Sciences, LP	13D/G 13F	Company	2.9%	530,796	$1,969,253	-$90,780,747	31 Dec 2025	13D/G 13F
Assenagon Asset Management S.A.	13F	Company	2.8%	508,414	$1,886,216	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	400,363	$1,485,685	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	1.8%	330,134	$1,224,797	—	31 Dec 2025	13F
Steven S. Williamson	3/4/5	Chief Commercial Officer	— class O/S missing	320,347	$1,143,639	—	15 Feb 2024	3/4/5
Jean-Olivier Racine	3/4/5	Chief Technology Officer	— class O/S missing	265,325	$867,613	—	10 May 2024	3/4/5
NORTHERN TRUST CORP	13F	Company	1.3%	232,587	$862,898	—	31 Dec 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1%	180,363	$669,146	—	31 Dec 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.98%	177,681	$659,197	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	0.94%	170,758	$633,512	—	31 Dec 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.87%	158,352	$587,372	—	31 Dec 2025	13F
Leslie Trigg	3/4/5	Chair and CEO, Director	0.8%	144,592	$582,824	-$122,515	17 Feb 2026	3/4/5
Brent D. Lang	3/4/5	Director	0.19%	34,517	$528,109	—	02 Jun 2025	3/4/5
MORGAN STANLEY	13F	Company	0.77%	139,719	$518,358	—	31 Dec 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.7%	127,268	$468,000	—	31 Dec 2025	13F
Martin Vazquez	3/4/5	Chief Operating Officer	— mixed-class rows	146,619 mixed-class rows	$442,350	—	01 Mar 2023	3/4/5
Catalio Capital Management, LP	13F	Company	0.65%	118,279	$438,815	—	31 Dec 2025	13F
D. Keith Grossman	3/4/5	Director	0.15%	26,763	$409,473	—	02 Jun 2025	3/4/5
JPMORGAN CHASE & CO	13F	Company	0.6%	109,376	$405,785	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.56%	100,612	$373,271	—	31 Dec 2025	13F
Kevin C. Oboyle	3/4/5	Director	0.13%	24,118	$369,005	—	02 Jun 2025	3/4/5
Birchview Capital, LP	13F	Company	0.54%	98,913	$366,967	—	31 Dec 2025	13F
GMT CAPITAL CORP	13F	Company	0.54%	98,108	$363,981	—	31 Dec 2025	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.03%	5,000	$309,167	—	31 Dec 2025	13F
STIFEL FINANCIAL CORP	13F	Company	0.44%	79,924	$296,516	—	31 Dec 2025	13F
Nabeel Ahmed	3/4/5	Chief Financial Officer	0.09%	16,096	$286,669	-$10,401	15 May 2025	3/4/5
James F. Hinrichs.	3/4/5	Director	— class O/S missing	80,349	$283,632	—	29 May 2024	3/4/5
UBS Group AG	13F	Company	0.4%	73,160	$271,424	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.4%	72,698	$269,710	—	31 Dec 2025	13F
Stacey L. Porter	3/4/5	Chief People Officer	— class O/S missing	61,448	$263,612	—	12 Jan 2024	3/4/5
C WorldWide Group Holding A/S	13F	Company	0.37%	66,666	$247,000	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	0.36%	65,304	$242,278	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.33%	59,925	$222,321	—	31 Dec 2025	13F
Squarepoint Ops LLC	13F	Company	0.33%	59,285	$219,947	—	31 Dec 2025	13F
Graham Capital Management, L.P.	13F	Company	0.28%	51,070	$189,470	—	31 Dec 2025	13F
Andrea Lynn Saia	3/4/5	Director	0.07%	12,175	$186,277	—	02 Jun 2025	3/4/5
Engineers Gate Manager LP	13F	Company	0.28%	50,178	$186,160	—	31 Dec 2025	13F

Institutional Holders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) as of Q1 2026

As of 31 Mar 2026, Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 792,343 shares. The largest 10 holders included Assenagon Asset Management S.A., Stratos Wealth Partners, LTD., Nuveen, LLC, R Squared Ltd, Police & Firemen's Retirement System of New Jersey, GAMMA Investing LLC, Sterling Capital Management LLC, MassMutual Private Wealth & Trust, FSB, Root Financial Partners, LLC, and Fortitude Family Office, LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-76

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.